20-3659928-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_022139.4(GFRA4):c.791C>T(p.Ala264Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000623 in 1,445,208 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022139.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GFRA4 | NM_022139.4 | c.791C>T | p.Ala264Val | missense_variant | 6/6 | ENST00000290417.7 | NP_071422.1 | |
GFRA4 | NM_145762.3 | c.881C>T | p.Ala294Val | missense_variant | 5/5 | NP_665705.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GFRA4 | ENST00000290417.7 | c.791C>T | p.Ala264Val | missense_variant | 6/6 | 1 | NM_022139.4 | ENSP00000290417.2 | ||
GFRA4 | ENST00000319242.8 | c.881C>T | p.Ala294Val | missense_variant | 5/5 | 1 | ENSP00000313423.3 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD3 exomes AF: 0.0000136 AC: 3AN: 220100Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 118248
GnomAD4 exome AF: 0.00000623 AC: 9AN: 1445208Hom.: 0 Cov.: 32 AF XY: 0.00000279 AC XY: 2AN XY: 716808
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 12, 2022 | The c.881C>T (p.A294V) alteration is located in exon 5 (coding exon 5) of the GFRA4 gene. This alteration results from a C to T substitution at nucleotide position 881, causing the alanine (A) at amino acid position 294 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at